Panaspar, 316 mg+280 mg 50 pcs.

To eliminate potassium and magnesium deficiency in combination therapy for various manifestations of coronary heart disease (including acute myocardial infarction);

Active ingredient

Potassium asparaginate, Magnesium asparaginate

Composition

film-coated

How to take, the dosage

You should consult your doctor before use.

Special Instructions

Patients with diseases accompanied by hyperkalemia require special attention: regular monitoring of plasma potassium content is necessary.

Contraindications

Hypersensitivity to any of the drug components, acute and chronic renal failure, hyperkalemia, hypermagnesemia, Addison’s disease, 1st – 3rd degree atrioventricular block, shock (including cardiogenic shock) (blood pressure less than 90 mm Hg), amino acid metabolism disorders, severe myasthenia, hemolysis, acute metabolic acidosis, dehydration state, age less than 18 years (effectiveness and safety are not established).

Side effects

Nausea, vomiting, diarrhea, discomfort or burning in the epigastrium (in patients with anacid gastritis or cholecystitis), atrioventricular blockade, paradoxical reaction (increased number of extrasystoles) are possible, hyperkalemia (nausea, vomiting, diarrhea, paresthesias), hypermagnesemia (redness of face, feeling of thirst, decreased blood pressure, hyporeflexia, respiratory depression, seizures).

Overdose

There is an increased risk of symptoms of hyperkalemia and hypermagnesemia.

Pregnancy use

Use is possible if the potential benefit to the mother exceeds the possible risk to the fetus.

Similarities

Panangin, Asparkam, Potassium and Magnesium Asparaginate, Asparkam-L